Great Lakes Retirement’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
7,211
+225
+3% +$48.4K 0.16% 125
2026
Q1
$1.52M Buy
6,986
+286
+4% +$63.4K 0.16% 131
2025
Q4
$1.53M Buy
6,700
+216
+3% +$49.2K 0.16% 126
2025
Q3
$1.5M Buy
6,484
+192
+3% +$39.1K 0.16% 127
2025
Q2
$1.17M Buy
6,292
+5,017
+393% +$932K 0.14% 139
2025
Q1
$267K Buy
1,275
+57
+5% +$11.1K 0.04% 198
2024
Q4
$216K Buy
+1,218
New +$224K 0.03% 203
2024
Q3
Sell
-855
Closed -$147K 201
2024
Q2
$147K Buy
+855
New +$142K 0.02% 201
2023
Q1
Sell
-7,542
Closed -$1.22M 220
2022
Q4
$1.22M Buy
+7,542
New +$1.16M 0.31% 52

Other funds holding ABBV

Great Lakes Retirement's ABBV Position: Q2 2026 in Review

Great Lakes Retirement increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $48.4K and bringing the position to 7,211 shares worth $1.81M. The position accounts for 0.16% of the portfolio, ranked #125.

Great Lakes Retirement first reported a position in ABBV in Q4 2022 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Great Lakes Retirement held 7,211 shares of AbbVie worth $1.81M as of Q2 2026.
  • Great Lakes Retirement bought 225 AbbVie shares in Q2 2026, an estimated $48.4K.
  • AbbVie made up 0.16% of Great Lakes Retirement's portfolio in Q2 2026, its #125 holding.
  • Great Lakes Retirement first reported a position in AbbVie in Q4 2022 and has held it in 9 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Great Lakes Retirement's 13F filing for Q2 2026, filed 30 Jul 2026.